These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 3251045

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Activation of the classic complement pathway in patients with the C3 nephritic factor.
    McLean RH, Siegel NJ, Kashgarian M.
    Nephron; 1980; 25(2):57-64. PubMed ID: 6986570
    [Abstract] [Full Text] [Related]

  • 24. Nephritic factor, C3 splitting activity, C3 and factor B breakdown products in glomerular diseases.
    De Vecchi A, Montagnino G, Scalia P, Tarantino A.
    Ric Clin Lab; 1980; 10(1):93-7. PubMed ID: 6781054
    [No Abstract] [Full Text] [Related]

  • 25. A C3 convertase assay for nephritic factor functional activity.
    Jelezarova E, Schlumberger M, Sadallah S, Späth PJ, Schifferli JA, Lutz HU.
    J Immunol Methods; 2001 May 01; 251(1-2):45-52. PubMed ID: 11292480
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Partial lipodystrophy and membranoproliferative glomerulonephritis. Apropos of a case].
    Martínez Debora MJ, Vázquez Martul M, Ecija Peiró JL, González Pérez J, Lirio Rodríguez J, González Mediero I.
    An Esp Pediatr; 1989 Jun 01; 30(6):499-502. PubMed ID: 2679278
    [Abstract] [Full Text] [Related]

  • 28. A properdin dependent nephritic factor slowly activating C3, C5, and C9 in membranoproliferative glomerulonephritis, types I and III.
    Clardy CW, Forristal J, Strife CF, West CD.
    Clin Immunol Immunopathol; 1989 Mar 01; 50(3):333-47. PubMed ID: 2917424
    [Abstract] [Full Text] [Related]

  • 29. Meningococcal meningitis associated with persistent hypocomplementaemia due to circulating C3 nephritic factor.
    Thompson RA, Yap PL, Brettle RB, Dunmow RE, Chapel H.
    Clin Exp Immunol; 1983 Apr 01; 52(1):153-6. PubMed ID: 6861372
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Partial lipodystrophy and glomerulonephritis without complement activation.
    Mery JP, Kourilsky O, Morel-Maroger L, Adam C.
    N Engl J Med; 1978 May 04; 298(18):1034. PubMed ID: 643001
    [No Abstract] [Full Text] [Related]

  • 33. C3 nephritic factor stabilization of the classic C3 convertase: a role for C2 in C3 nephritic factor activity.
    McLean RH, Nilson SH.
    Proc Soc Exp Biol Med; 1979 Jul 04; 161(3):358-63. PubMed ID: 461464
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Human polyclonal and monoclonal IgG and IgM complement 3 nephritic factors: evidence for idiotypic commonality.
    Tsokos GC, Stitzel AE, Patel AD, Hiramatsu M, Balow JE, Spitzer RE.
    Clin Immunol Immunopathol; 1989 Oct 04; 53(1):113-22. PubMed ID: 2475285
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Serum bactericidal activity against Neisseria meningitidis in patients with C3 nephritic factors is dependent on IgG allotypes.
    Skattum L, Gullstrand B, Holmström E, Oxelius VA, Truedsson L.
    Clin Immunol; 2008 Oct 04; 129(1):123-31. PubMed ID: 18667363
    [Abstract] [Full Text] [Related]

  • 40. IgG subclass studies of C3 nephritic factor.
    Davis AE, Gelfand EW, Schur PH, Rosen FS, Alper CA.
    Clin Immunol Immunopathol; 1978 Sep 04; 11(1):98-101. PubMed ID: 699392
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.